KDA Group Inc.

KDA Group Inc. is a Canadian publicly traded company specializing in technological and operational efficiency solutions for the general and specialized health sectors. Headquartered in Thetford Mines, Quebec, its mission is to accelerate digital healthcare transformation globally for both patients and healthcare professionals.

The company's core offerings include a suite of technology platforms designed for the healthcare market. These include Adherize+, an intelligent patient engagement platform for monitoring treatment adherence; Medherize, a specialized module of Adherize+ focused on complex therapies like oral oncology treatments; KRx, an advanced electronic prescription platform for medical clinics; and CareMedic, an integrated digital health record and care coordination platform.

In recent news, KDA Group Inc. appointed Jean-Marc Léveillé as President and CEO in February 2026, and Martin Kirouac as CTO of its subsidiary Groupe Technologique KDA Inc. in April 2026. The company completed a debt settlement in May 2026 and acquired the minority interest in its subsidiary Groupe Technologique KDA Inc. in March 2026. An independent evaluation in June 2026 confirmed the clinical and organizational benefits of its Medherize platform in breast oncology.